Non-Current Liabilities
Operating Lease Liabilities (Total)
Royalty Pharma Operating Lease Liabilities (Total) decreased by 4.0% to $18.49M in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026
How to read this metric
An increase indicates expansion of the leased asset base, while a decrease suggests a reduction in lease commitments or the expiration of lease terms.
Detailed definition
This represents the total present value of future lease payments for operating leases, recognized as a liability on the...
Peer comparison
Standardized under modern accounting rules, allowing for direct comparison of lease-based financing across companies in the same sector.
Metric ID:
operating_lease_liabilities_totalHistorical Data
4 periods
| Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $20.77M | $20.02M | $19.26M | $18.49M |
| QoQ Change | — | -3.6% | -3.8% | -4.0% |
Range$18.49M – $20.77M
Current Streak3+ quarters decline
Operating Lease Liabilities (Total) at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's operating lease liabilities (total)?
- Royalty Pharma (RPRX) reported operating lease liabilities (total) of $18.49M in Q1 2026.
- What does operating lease liabilities (total) mean?
- The total value of future payments the company is obligated to make for leased assets.